Laura Østergaard

LØ

Statistics

Publications

Citations

813

H-Index

Active since

2024

Affiliations

Düsseldorf University Hospital(Current)

Novo Nordisk (Denmark)

University of Birmingham

Inserm

Centre de Recherche des Cordeliers

Laura Østergaard is an author at Düsseldorf University Hospital specializing in metabolic dysfunction-associated steatotic liver disease fibrosis, liver disease, and metabolic liver disease.

Publications per year

2024–2025

Publications

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis

Philip N. Newsome, Iris Kliers, Laura Østergaard et al. · New England Journal of Medicine · 2025 · 690 citations

Medicine, Pharmacology, Pharmacotherapy +17

Semaglutide 2.4 mg in Participants With Metabolic Dysfunction‐Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 <scp>ESSENCE</scp> Trial

Philip N. Newsome, Arun J. Sanyal, Kristiane A. Engebretsen et al. · Alimentary Pharmacology & Therapeutics · 2024 · 123 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

1–2 of 2